Log in

OTCMKTS:BXRXV - Baudax Bio Stock Price, Forecast & News

$4.51
-1.27 (-21.97 %)
(As of 12/6/2019 06:00 AM ET)
Today's Range
$4.51
Now: $4.51
$4.51
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Baudax Bio, Inc. develops and markets products for the hospital and other acute care settings. The company was founded in 2019 and is based in Malvern, Pennsylvania. Baudax Bio, Inc. operates independently of Recro Pharma, Inc. as of November 21, 2019.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BXRXV
CUSIPN/A
CIKN/A
Phone484-395-2470

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive BXRXV News and Ratings via Email

Sign-up to receive the latest news and ratings for BXRXV and its competitors with MarketBeat's FREE daily newsletter.


Baudax Bio (OTCMKTS:BXRXV) Frequently Asked Questions

What is Baudax Bio's stock symbol?

Baudax Bio trades on the OTCMKTS under the ticker symbol "BXRXV."

What price target have analysts set for BXRXV?

2 brokerages have issued twelve-month price targets for Baudax Bio's shares. Their forecasts range from $12.00 to $12.00. On average, they anticipate Baudax Bio's share price to reach $12.00 in the next year. This suggests a possible upside of 166.1% from the stock's current price. View Analyst Price Targets for Baudax Bio.

What is the consensus analysts' recommendation for Baudax Bio?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baudax Bio in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baudax Bio.

Has Baudax Bio been receiving favorable news coverage?

Press coverage about BXRXV stock has trended somewhat negative on Friday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Baudax Bio earned a news sentiment score of -1.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Baudax Bio.

Who are some of Baudax Bio's key competitors?

How do I buy shares of Baudax Bio?

Shares of BXRXV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Baudax Bio's stock price today?

One share of BXRXV stock can currently be purchased for approximately $4.51.

What is Baudax Bio's official website?

The official website for Baudax Bio is http://www.baudaxbio.com/.

How can I contact Baudax Bio?

The company can be reached via phone at 484-395-2470.


MarketBeat Community Rating for Baudax Bio (OTCMKTS BXRXV)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  8
MarketBeat's community ratings are surveys of what our community members think about Baudax Bio and other stocks. Vote "Outperform" if you believe BXRXV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BXRXV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel